1.Current application and prospects of new ultrasound technologies in the diagnosis and treatment of hepatocellular carcinoma
Sijia LIN ; Lingling LI ; Jianhua ZHOU
Journal of Clinical Hepatology 2026;42(7):1507-1512
As a common type of primary liver cancer, hepatocellular carcinoma (HCC) is a major health threat in China. Ultrasound is a crucial imaging modality in the clinical diagnosis and treatment of HCC, and the development and application of new ultrasound technologies have high clinical value. Currently, ultrasound and contrast-enhanced ultrasound combined with artificial intelligence have shown promising potential in the detection of focal liver lesions, image-based HCC diagnosis, outcome assessment, and prognostic prediction; furthermore, ultrasound fusion imaging technology has shown certain clinical value in guidance and efficacy evaluation of percutaneous thermal ablation; three-dimensional ultrasound has certain advantages in assisting ablation and assessing ablation margins; endoscopic ultrasonography can be used as a supplementary method for HCC cases that are difficult to scan or guide via percutaneous ultrasound.
2.Long-term prognosis of liver cirrhosis patients with spontaneous portosystemic shunt undergoing secondary endoscopic preventive therapy for type 1 isolated gastric variceal bleeding
Yuling ZHOU ; Lingling HE ; Jiali MA ; Ping LI ; Hongshan WEI ; Zhenglin AI
Journal of Clinical Hepatology 2026;42(7):1614-1622
ObjectiveTo observe the long-term survival outcomes and complications of liver cirrhosis patients with spontaneous portosystemic shunt and type 1 isolated gastric varices (IGV-1) bleeding after secondary endoscopic preventive therapy, and to investigate the independent influencing factors for long-term prognosis. MethodsA total of 70 liver cirrhosis patients with spontaneous portosystemic shunt and IGV-1 bleeding who were admitted to Beijing Ditan Hospital, Capital Medical University, from January 5, 2015 to November 29, 2019 were enrolled as subjects, and related baseline data were collected, including age, sex, etiology, routine blood test results, liver function parameters, renal function parameters, coagulation parameters, Child-Pugh score, and the presence or absence of comorbidities such as cholestasis, hepatocellular carcinoma, thrombosis, ascites, and hepatic encephalopathy. All patients underwent secondary endoscopic preventive therapy for rebleeding and were followed up for 5 years. The primary endpoints were ectopic embolism rate and all-cause mortality rate, and the secondary endpoints were liver-related mortality and liver-related complications. The independent-samples t test or the Mann-Whitney U test was used for comparison of continuous data between groups, and the chi-square test was used for comparison of categorical data between groups. The Cox regression analysis was used to investigate the prognostic factors for 1-, 3-, and 5-year survival time, and the Logistic regression analysis was used to identify the independent risk factors for liver disease-related complications. ResultsThe incidence rate of ectopic embolism was 0% within 5 years of follow-up. The 1-, 3-, and 5-year all-cause mortality rates were 5.7%, 24.3%, and 32.9%, respectively. There were 2 cases of liver-related death in year 1, 8 cases in year 3, and 12 cases in year 5, resulting in a liver disease-related mortality rate of 17.14% (12/70). Compared with the survival group, the death group had significantly higher incidence rates of hepatocellular carcinoma (0.00% vs 17.39%, χ2=8.669, P=0.003) and ascites (38.30% vs 52.17%, χ2=7.272, P=0.026), and compared with the death group, the survival group had significantly lower 5-year incidence rates of rebleeding (10.64% vs 100.00%, χ2=51.383, P<0.001), ascites (8.51% vs 52.17%, χ2=21.574, P<0.001), and hepatic encephalopathy (0.00% vs 21.74%, χ2=12.029, P=0.002). The multivariate Cox regression analysis showed that during the 1-year follow-up, comorbidity with hepatocellular carcinoma before surgery (hazard ratio [HR]=14.601, 95% confidence interval [CI]: 2.049 — 104.098, P=0.007) and PT (HR=1.662, 95%CI: 1.090 — 2.535, P=0.018) were independent risk factors for survival, and HGB level (HR=0.863, 95%CI: 0.747 — 0.998, P=0.046) was a protective factor for prolonged survival; during the long-term follow-up for 3 or 5 years, preoperative comorbidities with hepatocellular carcinoma (3 years: HR=40.174, 95%CI: 8.939 — 180.559, P<0.001; 5 years: HR=26.739, 95%CI: 6.993 — 102.243, P<0.001) and ascites (3 years: HR=3.638, 95%CI: 1.751 — 7.575, P=0.001; 5 years: HR=2.555, 95%CI: 1.419 — 4.598, P=0.002) were independent risk factors for mortality. The Logistic regression analysis showed that during the follow-up for 3 years, comorbidity with ascites before surgery (odds ratio [OR]=0.255, 95%CI: 0.102 — 0.636, P=0.003) was associated with a lower risk of rebleeding, while comorbidity with hepatocellular carcinoma before surgery (OR=16.231, 95%CI: 1.298 — 202.878, P=0.031) was an independent risk factor for rebleeding; prothrombin time was a protective factor against hepatic encephalopathy (OR=0.790, 95%CI: 0.648 — 0.964, P=0.020); during the follow-up for 5 years, aggravation of ascites after surgery (OR=5.578, 95%CI: 1.474 — 21.103, P=0.011) was an independent risk factor for rebleeding, and aggravation of ascites after surgery (OR=175.046, 95%CI: 14.306 — 2 141.909, P<0.001) were independent risk factors for the development of ascites in the future. ConclusionComorbidity with hepatocellular carcinoma before surgery and prothrombin time are independent risk factors for 1-year survival, whereas a high HGB level is a protective factor for increasing 1-year survival. Preoperative comorbidities with hepatocellular carcinoma and ascites are independent risk factors for the long-term prognosis of patients with spontaneous portosystemic shunt and IGV-1 bleeding and can significantly shorten survival time. Preoperative comorbidity with ascites can reduce the occurrence of rebleeding, while postoperative hepatocellular carcinoma and aggravation of ascites after surgery are independent risk factors for rebleeding; aggravation of ascites after surgery is an independent risk factor for the development of ascites in the future.
3.Investigation of pneumoconiosis patients' hospitalization utilization and its influencing factors in a certain city
Xiaolan ZHOU ; Shaoteng SHI ; Xinyu XU ; Lingling QIAN ; Feng HAN ; Jiao LI
Chinese Journal of Industrial Hygiene and Occupational Diseases 2025;43(5):368-372
Objective:To investigate the hospitalization utilization of pneumoconiosis patients and its influencing factors in a northwestern city, and to provide theoretical basis for formulating service policies for pneumoconiosis patients.Methods:From March to October 2021. Existing living pneumoconiosis patients in kashgar were selected as the research objects. The "Survey Questionnaire on Medical Behaviors and Influencing Factors of Pneumoconiosis Patients" developed by the National Institute of Occupational Health and Poison Control of China Centers for Disease Control and Prevention was used to collect pneumoconiosis patients infomations from March to October 2021. This study investigated the demographic characteristics of pneumoconiosis patients, the types and stages of pneumoconiosis, as well as hospitalization in the past year, reasons for hospitalization, treatment measures, reasons for discharge. Additionally, it examined factors influencing medical behaviors, including medical insurance reimbursement, work-related injury insurance, and compensation situations.Logistics regression was used to analyze the influencing factors of hospitalization utilization.Results:The average age of the pneumoconiosis patients was elder with the age of 64.8. 86.7% (156/178) of them were retired, 75.8% (135/178) of them relied primarily on pensions for their income. The main types of pneumoconiosis were silicosis and coal workers' pneumoconiosis with the proportion of 57.3% (102/178) and 24.2% (43/178). 67.4% of them were stage I. The hospitalization rate in the year prior to the survey was 37.1%. The factors that promoted hospitalization were pension as the main source of income, pneumoconiosis in stage II, silicosis as the pneumoconiosis type, suffering joint pain, with two OR more other lung diseases (tuberculosis, cor pulmonale, COPD, pulmonary infection, bulla or pneumothorax, lung cancer, or mesothelioma) ( P<0.05) . Conclusion:The hospitalization rate of pneumoconiosis patients in the previous year was low. It is mainly influenced by the patient's economic income, the duration of pneumoconiosis, and the presence of comorbidities.
4.Clinical effects of hearing aids in the treatment of chronic subjective tinnitus with hearing loss
Lingling ZHOU ; Jing ZHOU ; Zhao HAN ; Yuehong LIU
Chinese Archives of Otolaryngology-Head and Neck Surgery 2025;32(2):90-93
OBJECTIVE To explore the therapeutic effect of hearing aids on chronic subjective tinnitus with moderate to severe sensorineural hearing loss.METHODS Ninety-five patients were enrolled in this prospective study.Pure tone audiometry,acoustic immittance and tinnitus were performed before hearing aids were worn.The tinnitus handicap inventory(THI),hospital anxiety and depression scale(HADS)and visual analogue scale(VAS)were completed before and after 3 and 6 months after wearing the device.SPSS 22 was used for statistical analysis.RESULTS After 3 months and 6 months of hearing aid wearing,THI,HADS and VAS scores of the patients were significantly decreased,and there were significant differences before and after wearing the hearing aid(P<0.05).The THI score of patients in the catastrophic group decreased the most,reaching 44.5 points.Age,gender,duration of tinnitus,the side of tinnitus and the degree of hearing loss have no effect on the treatment effect of hearing aids.CONCLUSION Hearing aids can not only improve the hearing of patients,but also reduce tinnitus,relieve anxiety and depression.
5.Effect of acupuncture on postoperative delirium in diabetic patients undergoing surgery under general anesthesia
Jiaxi LIU ; Qi WANG ; Lingling DING ; Jiaqi NING ; Hai KE ; Zhuoya CHEN ; Bo YU ; Weiming SUN ; Peng CHEN ; Xiang LI ; Shishun KOU ; Reiling ZHOU ; Yudong ZHOU ; Yan GUO ; Mengjie CHEN ; Ruyu YAN ; Jiansheng LUO
Chinese Journal of Anesthesiology 2025;45(10):1313-1316
Objective:To evaluate the effect of acupuncture on postoperative delirium (POD) in diabetic patients undergoing surgery under general anesthesia.Methods:In this randomized controlled trial, 92 diabetic patients of either sex, aged 30-80 yr, with a body mass index of 18-28 kg/m 2, of American Society of Anesthesiologists Physical Status classification Ⅱ or Ⅲ, scheduled for elective surgery under general anesthesia, were divided into 2 groups ( n=46 each) using a table of random numbers: control group (group C) and acupuncture group (group A). Group A received acupuncture at the Baihui (GV20), Shenting (GV24) and Sishencong (EX-HN1) acupoints before anesthesia. The needles were retained for 30 min, with manual stimulation applied every 10 min for 10 s each time. After 4 stimulations, routine anesthesia was carried out. Group C received routine anesthesia only. Regional cerebral oxygen saturation was recorded on admission to the operating room (T 0), after anesthesia induction (T 1), at the start of surgery (T 2), at the end of surgery (T 3), and immediately after tracheal extubation (T 4). The POD developed within 3 days after surgery was assessed. The occurrence of needle-related adverse effects such as fainting, subcutaneous bleeding, and local paresthesia was recorded. Results:Compared with group C, the incidence of POD was significantly reduced, and the regional cerebral oxygen saturation was increased at T 1, 4 in group A ( P<0.05). Conclusions:Acupuncture can decrease the development of POD in diabetic patients undergoing surgery under general anesthesia, which is related to an increase in regional cerebral oxygen saturation.
6.Practice of multidrug-resistant organism management under the mode of information reminder system combined with multidisciplinary collaboration
Liyuan QIN ; Shengbin ZHOU ; Qiufeng LAO ; Lingling XIE ; Li'e WANG ; Hong-hong FU ; Peiyun WU ; Jiaguang HU
Chinese Journal of Infection Control 2025;24(11):1641-1646
Objective To explore the application effect of constructing a data sharing-based multidrug-resistant or-ganism(MDRO)information reminder system combined with multidisciplinary standardized measures on the whole-process closed-loop management of MDRO.Methods Hospitalized patients from whom MDRO were detected from January 1 to July 31,2024 were taken as the control group,those from August 1,2024,to May 31,2025 were as the intervention group.The control group adopted the traditional manual reporting mode for MDRO,while the in-tervention group adopted the combination of MDRO reminder system and multidisciplinary management mode.Differences in isolation order issuing rate for MDRO and process-and outcome-indicators for multidisciplinary spe-cialty before and after system implementation were compared.Results After implementing information reminder system combined with multidisciplinary measures,issuing rates of ≤24 hour and<4 hour MDRO isolation orders in the intervention group were both higher than in the control group([90.20%vs 65.23%,P<0.05],[80.64%vs 55.08%,P<0.001],respectively).Antimicrobial use rate in the intervention group was lower than in the con-trol group(36.27%vs 43.41%),with a statistically significant difference(P<0.05).The implementation rates of MDRO prevention and control measures,pathogen detection rates,and fluorescence labeling clearance rates in the intervention group were all higher than those in the control group,all with statistically significant differences(all P<0.05).The detection rate of MDRO decreased compared with the control group(10.83%vs 16.49%),and the in-cidence of MDRO healthcare-associated infection in the intervention group was lower than that in the control group(0.09%vs 0.19%),both with statistically significant differences(both P<0.001).The treatment expense in the intervention group reduced by 27 422 Yuan compared with the control group.Conclusion This study constructed an MDRO reminder system,realized full-chain monitoring system for the multidisciplinary MDRO information interac-tion platform,strengthened multidisciplinary in-depth integration,and improved the prevention and control effect for MDRO.
7.Clinical characteristics combined with inflammatory markers for predicting prognosis of patients with acute ischemic stroke after mechanical thrombectomy
Lingling ZHOU ; Xuchen MENG ; Weijie ZHONG ; Zhaoliang SUN ; Xiaohong SHI ; Tanjun DENG ; Zixian MEI ; Jiexi XIAO ; Dingzhong TANG ; Yi LI
Academic Journal of Naval Medical University 2025;46(10):1290-1296
Objective To explore the potential prognostic factors of patients with acute ischemic stroke(AIS)after undergoing endovascular mechanical thrombectomy and to construct an effective predictive model.Methods A retrospective analysis of clinical data was conducted on 202 patients with anterior circulation large vessel occlusion AIS from 2 stroke centers.All patients received endovascular mechanical thrombectomy treatment,with treatment and follow-up lasting at least 90 d.Basic demographic characteristics,medical records,and baseline blood biomarker data were collected,and the potential prognostic indicators for AIS after 90 d were screened using least absolute shrinkage and selection operator(LASSO)-logistic regression analysis.Results It was found that alcohol drinking(P=0.029),hypertension(P=0.001),diabetes mellitus(P=0.021),stroke or transient ischemic attack(P=0.049),systolic blood pressure on admission(P=0.009),diastolic blood pressure on admission(P=0.038),blood glucose(P=0.003),white blood cell count(P=0.001),neutrophil count(P=0.001),fibrinogen(P=0.010),systemic immune-inflammation index(P=0.008)and neutrophil-to-lymphocyte ratio(NLR)(P<0.001)were associated with adverse clinical outcomes.Nine significant prognostic determinants were screened through LASSO-logistic regression analysis.Multivariate logistic regression analysis revealed that male sex(P=0.008),smoking history(P=0.013),hypertension(P=0.011),lymphocyte(P=0.028),fibrinogen(P=0.016),and NLR(P<0.001)were significant predictive factors for poor prognosis in AIS patients after endovascular thrombectomy treatment.The constructed prognostic model had an accuracy of 76.2%,a sensitivity of 78.2%,a specificity of 71.7%,and a positive predictive value of 86.7%.Conclusion The predictive model established in this study can assist clinicians in identifying high-risk patients with AIS who have undergone endovascular thrombectomy,and it provide guidance for formulating individualized treatment strategies.
8.Advancements in Research on Preoperative Localization of Pulmonary Nodules.
Jialong CHEN ; Lei ZHOU ; Lingling QIN ; Chunlai LIU
Chinese Journal of Lung Cancer 2025;28(5):385-390
In recent years, the widespread application of chest computed tomography (CT) screening has led to a significant increase in the detection rate of pulmonary nodules. As a critical diagnostic tool for early-stage lung cancer, video-assisted thoracic surgery (VATS) has emerged as the preferred therapeutic approach for pulmonary nodules. Clinical evidence demonstrates that precise preoperative localization significantly enhances surgical success rates (reducing conversion to thoracotomy), minimizes complications, and shortens operation time. This comprehensive review systematically evaluates six cutting-edge localization techniques: percutaneous puncture-assisted localization, electromagnetic navigation bronchoscopy (ENB) localization, 3D-printed auxiliary localization, basin-analysis-based localization, robotic navigation system localization, and mixed reality (MR)-guided localization. By critically analyzing their operational principles, efficacy, safety profiles, and clinical applicability, this paper aims to provide evidence-based recommendations for optimizing clinical decision-making in pulmonary nodule management.
.
Humans
;
Lung Neoplasms/diagnosis*
;
Solitary Pulmonary Nodule/diagnostic imaging*
;
Thoracic Surgery, Video-Assisted/methods*
;
Multiple Pulmonary Nodules/diagnostic imaging*
;
Tomography, X-Ray Computed
9.Catalpol reduces liver toxicity of triptolide in mice by inhibiting hepatocyte ferroptosis through the SLC7A11/GPX4 pathway: testing the Fuzheng Zhidu theory for detoxification.
Linluo ZHANG ; Changqing LI ; Lingling HUANG ; Xueping ZHOU ; Yuanyuan LOU
Journal of Southern Medical University 2025;45(4):810-818
OBJECTIVES:
To investigate the protective effect of catalpol against triptolide-induced liver injury and explore its mechanism to test the Fuzheng Zhidu theory for detoxification.
METHODS:
C57BL/6J mice were randomized into blank control group, catalpol group, triptolide group and triptolide+catalpol group. After 13 days of treatment with the agents by gavage, the mice were examined for liver tissue pathology, liver function, hepatocyte subcellular structure, lipid peroxidation, ferrous ion deposition and expressions of ferroptosis-related proteins in the liver. In a liver cell line HL7702, the effect of catalpol or the ferroptosis inhibitor Fer-1 on triptolide-induced cytotoxicity was tested by examining cell functions, Fe2+ concentration, lipid peroxidation, ROS level and the ferroptosis-related proteins.
RESULTS:
In C57BL/6J mice, catalpol significantly alleviated triptolide-induced hepatic injury, lowered the levels of ALT, AST and LDH, and reversed the elevation of Fe2+ concentration and MDA level and the reduction of GPX level. In HL7702 cells, inhibition of ferroptosis by Fer-1 significantly reversed triptolide-induced elevation of ALT, AST and LDH levels. Western blotting and qRT-PCR demonstrated that catalpol reversed abnormalities in expressions of SLC7A11, FTH1 and GPX4 at both the mRNA and protein levels in triptolide-treated HL7702 cells.
CONCLUSIONS
The combined use of catalpol can reduce the hepatotoxicity of triptolide in mice by inhibiting excessive hepatocyte ferroptosis through the SLC7A11/GPX4 pathway.
Animals
;
Phenanthrenes/toxicity*
;
Ferroptosis/drug effects*
;
Diterpenes/toxicity*
;
Epoxy Compounds/toxicity*
;
Mice, Inbred C57BL
;
Hepatocytes/metabolism*
;
Mice
;
Phospholipid Hydroperoxide Glutathione Peroxidase
;
Iridoid Glucosides/pharmacology*
;
Liver/metabolism*
;
Chemical and Drug Induced Liver Injury/prevention & control*
;
Male
;
Amino Acid Transport System y+/metabolism*
10.Effect of glycolytic metabolic signal on differentiation of Th17 cells in rheumatoid arthritis
Xue CHEN ; Yu GE ; Lingling ZHOU
Chinese Journal of Immunology 2025;41(9):2106-2116
Rheumatoid arthritis(RA)is a chronic autoimmune disease characterized by inflammation of synovial tissue.Ab-normal differentiation of Th17 cells may affect the progression of RA.Besides,the growth and function of Th17 cells depend on glycoly-sis.In this paper,the relationship between glycolysis-mediated differentiation of Th17 cells and the development of RA was discussed.Following that,the glycolytic metabolic signals were introduced in two aspects.These included Glut1,HK-Ⅱ,PFK-1,PFKFB3,PKM2,LDHA,and other glycolytic enzymes(proteins),as well as mTOR,HIF-1α,AMPK,NRs,and other glycolytic sensors.In addition,we displayed relevant research efforts on treating autoimmune disease,such as RA.These studies contribute to pertinent studies for the clinical treatment of RA by offering useful metabolic targets.Finally,the research progress on improving RA through the inhibition of glycolysis by active components of traditional Chinese medicine(TCM)was described,indicating the potential of TCM in targeting glycolytic metabolic signals for the treatment of autoimmune diseases.

Result Analysis
Print
Save
E-mail